nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Pefloxacin—TOP2A—hematologic cancer	0.00517	0.319	CrCbGaD
Nalidixic Acid—Enoxacin—TOP2A—hematologic cancer	0.00484	0.298	CrCbGaD
Nalidixic Acid—Lomefloxacin—TOP2A—hematologic cancer	0.00367	0.226	CrCbGaD
Nalidixic Acid—Norfloxacin—TOP2A—hematologic cancer	0.00254	0.157	CrCbGaD
Nalidixic Acid—TDO2—Monoamine Transport—TNFRSF11B—hematologic cancer	0.00147	0.104	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—FTCD—hematologic cancer	0.000963	0.0679	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—hematologic cancer	0.000823	0.0581	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—ASNS—hematologic cancer	0.000769	0.0543	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—HDC—hematologic cancer	0.000729	0.0515	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TSC2—hematologic cancer	0.000684	0.0483	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—MAPK14—hematologic cancer	0.000652	0.046	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—MTAP—hematologic cancer	0.000567	0.04	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—IL1B—hematologic cancer	0.000427	0.0301	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Thalidomide—hematologic cancer	0.000399	0.000411	CcSEcCtD
Nalidixic Acid—Dizziness—Thiotepa—hematologic cancer	0.000398	0.000411	CcSEcCtD
Nalidixic Acid—Asthenia—Alitretinoin—hematologic cancer	0.000398	0.00041	CcSEcCtD
Nalidixic Acid—Rash—Vinorelbine—hematologic cancer	0.000398	0.00041	CcSEcCtD
Nalidixic Acid—Dermatitis—Vinorelbine—hematologic cancer	0.000397	0.00041	CcSEcCtD
Nalidixic Acid—Headache—Vinorelbine—hematologic cancer	0.000395	0.000407	CcSEcCtD
Nalidixic Acid—Asthenia—Ifosfamide—hematologic cancer	0.000393	0.000405	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000392	0.000405	CcSEcCtD
Nalidixic Acid—Pruritus—Alitretinoin—hematologic cancer	0.000392	0.000404	CcSEcCtD
Nalidixic Acid—Vertigo—Dexamethasone—hematologic cancer	0.000392	0.000404	CcSEcCtD
Nalidixic Acid—Vertigo—Betamethasone—hematologic cancer	0.000392	0.000404	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—hematologic cancer	0.000391	0.000403	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000389	0.000401	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—hematologic cancer	0.000388	0.000401	CcSEcCtD
Nalidixic Acid—Pruritus—Ifosfamide—hematologic cancer	0.000388	0.0004	CcSEcCtD
Nalidixic Acid—Dizziness—Thalidomide—hematologic cancer	0.000385	0.000397	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—hematologic cancer	0.000385	0.000397	CcSEcCtD
Nalidixic Acid—Nausea—Bortezomib—hematologic cancer	0.000384	0.000396	CcSEcCtD
Nalidixic Acid—Asthenia—Vincristine—hematologic cancer	0.000383	0.000395	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisolone—hematologic cancer	0.000383	0.000395	CcSEcCtD
Nalidixic Acid—Vomiting—Thiotepa—hematologic cancer	0.000383	0.000395	CcSEcCtD
Nalidixic Acid—Diarrhoea—Carmustine—hematologic cancer	0.000383	0.000395	CcSEcCtD
Nalidixic Acid—Nausea—Bleomycin—hematologic cancer	0.000381	0.000393	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—hematologic cancer	0.00038	0.000392	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—hematologic cancer	0.00038	0.000392	CcSEcCtD
Nalidixic Acid—Rash—Thiotepa—hematologic cancer	0.00038	0.000392	CcSEcCtD
Nalidixic Acid—Dermatitis—Thiotepa—hematologic cancer	0.000379	0.000391	CcSEcCtD
Nalidixic Acid—Diarrhoea—Alitretinoin—hematologic cancer	0.000379	0.000391	CcSEcCtD
Nalidixic Acid—Convulsion—Betamethasone—hematologic cancer	0.000378	0.00039	CcSEcCtD
Nalidixic Acid—Convulsion—Dexamethasone—hematologic cancer	0.000378	0.00039	CcSEcCtD
Nalidixic Acid—Headache—Thiotepa—hematologic cancer	0.000377	0.000389	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000377	0.000389	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ifosfamide—hematologic cancer	0.000375	0.000387	CcSEcCtD
Nalidixic Acid—Nausea—Vinorelbine—hematologic cancer	0.000375	0.000386	CcSEcCtD
Nalidixic Acid—Asthenia—Mitoxantrone—hematologic cancer	0.000373	0.000385	CcSEcCtD
Nalidixic Acid—Asthenia—Irinotecan—hematologic cancer	0.000373	0.000385	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000373	0.000384	CcSEcCtD
Nalidixic Acid—Vomiting—Thalidomide—hematologic cancer	0.00037	0.000382	CcSEcCtD
Nalidixic Acid—Dizziness—Carmustine—hematologic cancer	0.00037	0.000382	CcSEcCtD
Nalidixic Acid—Rash—Thalidomide—hematologic cancer	0.000367	0.000379	CcSEcCtD
Nalidixic Acid—Dermatitis—Thalidomide—hematologic cancer	0.000367	0.000378	CcSEcCtD
Nalidixic Acid—Dizziness—Alitretinoin—hematologic cancer	0.000366	0.000378	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vincristine—hematologic cancer	0.000365	0.000377	CcSEcCtD
Nalidixic Acid—Headache—Thalidomide—hematologic cancer	0.000365	0.000376	CcSEcCtD
Nalidixic Acid—Asthenia—Gemcitabine—hematologic cancer	0.000363	0.000375	CcSEcCtD
Nalidixic Acid—Dizziness—Ifosfamide—hematologic cancer	0.000362	0.000374	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.00036	0.000371	CcSEcCtD
Nalidixic Acid—Pruritus—Gemcitabine—hematologic cancer	0.000358	0.00037	CcSEcCtD
Nalidixic Acid—Nausea—Thiotepa—hematologic cancer	0.000358	0.000369	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000357	0.000369	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000356	0.000367	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Betamethasone—hematologic cancer	0.000356	0.000367	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—MDM2—hematologic cancer	0.000356	0.0251	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Irinotecan—hematologic cancer	0.000356	0.000367	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mitoxantrone—hematologic cancer	0.000356	0.000367	CcSEcCtD
Nalidixic Acid—Vomiting—Carmustine—hematologic cancer	0.000356	0.000367	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—hematologic cancer	0.000354	0.000365	CcSEcCtD
Nalidixic Acid—Dizziness—Vincristine—hematologic cancer	0.000353	0.000364	CcSEcCtD
Nalidixic Acid—Rash—Carmustine—hematologic cancer	0.000353	0.000364	CcSEcCtD
Nalidixic Acid—Dermatitis—Carmustine—hematologic cancer	0.000352	0.000363	CcSEcCtD
Nalidixic Acid—Vomiting—Alitretinoin—hematologic cancer	0.000352	0.000363	CcSEcCtD
Nalidixic Acid—Paraesthesia—Triamcinolone—hematologic cancer	0.000352	0.000363	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—hematologic cancer	0.000352	0.000363	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—hematologic cancer	0.000351	0.000363	CcSEcCtD
Nalidixic Acid—Headache—Carmustine—hematologic cancer	0.00035	0.000361	CcSEcCtD
Nalidixic Acid—Rash—Alitretinoin—hematologic cancer	0.000349	0.00036	CcSEcCtD
Nalidixic Acid—Dermatitis—Alitretinoin—hematologic cancer	0.000349	0.00036	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000349	0.00036	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000349	0.00036	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Betamethasone—hematologic cancer	0.000349	0.00036	CcSEcCtD
Nalidixic Acid—Vomiting—Ifosfamide—hematologic cancer	0.000348	0.000359	CcSEcCtD
Nalidixic Acid—Headache—Alitretinoin—hematologic cancer	0.000347	0.000358	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—hematologic cancer	0.000347	0.000358	CcSEcCtD
Nalidixic Acid—Diarrhoea—Gemcitabine—hematologic cancer	0.000347	0.000357	CcSEcCtD
Nalidixic Acid—Nausea—Thalidomide—hematologic cancer	0.000346	0.000357	CcSEcCtD
Nalidixic Acid—Rash—Ifosfamide—hematologic cancer	0.000345	0.000356	CcSEcCtD
Nalidixic Acid—Dermatitis—Ifosfamide—hematologic cancer	0.000345	0.000356	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—hematologic cancer	0.000345	0.000356	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.000345	0.000356	CcSEcCtD
Nalidixic Acid—Dizziness—Irinotecan—hematologic cancer	0.000344	0.000355	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—hematologic cancer	0.000344	0.000354	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—hematologic cancer	0.000342	0.000353	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—hematologic cancer	0.000341	0.000352	CcSEcCtD
Nalidixic Acid—Vomiting—Vincristine—hematologic cancer	0.00034	0.00035	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisolone—hematologic cancer	0.000339	0.00035	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—hematologic cancer	0.000339	0.000349	CcSEcCtD
Nalidixic Acid—Rash—Vincristine—hematologic cancer	0.000337	0.000347	CcSEcCtD
Nalidixic Acid—Dermatitis—Vincristine—hematologic cancer	0.000336	0.000347	CcSEcCtD
Nalidixic Acid—Headache—Vincristine—hematologic cancer	0.000335	0.000345	CcSEcCtD
Nalidixic Acid—Nausea—Carmustine—hematologic cancer	0.000332	0.000343	CcSEcCtD
Nalidixic Acid—Vomiting—Irinotecan—hematologic cancer	0.000331	0.000341	CcSEcCtD
Nalidixic Acid—Vomiting—Mitoxantrone—hematologic cancer	0.000331	0.000341	CcSEcCtD
Nalidixic Acid—Nausea—Alitretinoin—hematologic cancer	0.000329	0.00034	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—hematologic cancer	0.000329	0.000339	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—hematologic cancer	0.000329	0.000339	CcSEcCtD
Nalidixic Acid—Rash—Irinotecan—hematologic cancer	0.000328	0.000338	CcSEcCtD
Nalidixic Acid—Rash—Mitoxantrone—hematologic cancer	0.000328	0.000338	CcSEcCtD
Nalidixic Acid—Dermatitis—Mitoxantrone—hematologic cancer	0.000328	0.000338	CcSEcCtD
Nalidixic Acid—Dermatitis—Irinotecan—hematologic cancer	0.000328	0.000338	CcSEcCtD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—MTR—hematologic cancer	0.000326	0.023	CbGpPWpGaD
Nalidixic Acid—Headache—Irinotecan—hematologic cancer	0.000326	0.000336	CcSEcCtD
Nalidixic Acid—Headache—Mitoxantrone—hematologic cancer	0.000326	0.000336	CcSEcCtD
Nalidixic Acid—Nausea—Ifosfamide—hematologic cancer	0.000325	0.000336	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000324	0.000335	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000324	0.000335	CcSEcCtD
Nalidixic Acid—Arthralgia—Prednisone—hematologic cancer	0.000323	0.000334	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—hematologic cancer	0.000323	0.000333	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—hematologic cancer	0.000323	0.000333	CcSEcCtD
Nalidixic Acid—Vomiting—Gemcitabine—hematologic cancer	0.000322	0.000332	CcSEcCtD
Nalidixic Acid—Paraesthesia—Dexamethasone—hematologic cancer	0.00032	0.00033	CcSEcCtD
Nalidixic Acid—Paraesthesia—Betamethasone—hematologic cancer	0.00032	0.00033	CcSEcCtD
Nalidixic Acid—Rash—Gemcitabine—hematologic cancer	0.000319	0.000329	CcSEcCtD
Nalidixic Acid—Dermatitis—Gemcitabine—hematologic cancer	0.000319	0.000329	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—hematologic cancer	0.000318	0.000327	CcSEcCtD
Nalidixic Acid—Headache—Gemcitabine—hematologic cancer	0.000317	0.000327	CcSEcCtD
Nalidixic Acid—Nausea—Vincristine—hematologic cancer	0.000317	0.000327	CcSEcCtD
Nalidixic Acid—Urticaria—Triamcinolone—hematologic cancer	0.000312	0.000321	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—hematologic cancer	0.00031	0.00032	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—hematologic cancer	0.00031	0.00032	CcSEcCtD
Nalidixic Acid—TDO2—Monoamine Transport—TNF—hematologic cancer	0.00031	0.0219	CbGpPWpGaD
Nalidixic Acid—Nausea—Irinotecan—hematologic cancer	0.000309	0.000319	CcSEcCtD
Nalidixic Acid—Nausea—Mitoxantrone—hematologic cancer	0.000309	0.000319	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—hematologic cancer	0.000306	0.000316	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—hematologic cancer	0.000304	0.000314	CcSEcCtD
Nalidixic Acid—Nausea—Gemcitabine—hematologic cancer	0.000301	0.00031	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—hematologic cancer	0.0003	0.00031	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—hematologic cancer	0.000299	0.000308	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—hematologic cancer	0.000298	0.000307	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—hematologic cancer	0.000297	0.000307	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—hematologic cancer	0.000297	0.000306	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—hematologic cancer	0.000296	0.000305	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000291	0.0003	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000291	0.0003	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—hematologic cancer	0.000286	0.000295	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—hematologic cancer	0.000285	0.000294	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—hematologic cancer	0.000284	0.000293	CcSEcCtD
Nalidixic Acid—Urticaria—Betamethasone—hematologic cancer	0.000283	0.000292	CcSEcCtD
Nalidixic Acid—Urticaria—Dexamethasone—hematologic cancer	0.000283	0.000292	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000282	0.000291	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisolone—hematologic cancer	0.000282	0.000291	CcSEcCtD
Nalidixic Acid—Asthenia—Triamcinolone—hematologic cancer	0.000282	0.00029	CcSEcCtD
Nalidixic Acid—Abdominal pain—Betamethasone—hematologic cancer	0.000281	0.00029	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dexamethasone—hematologic cancer	0.000281	0.00029	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—hematologic cancer	0.00028	0.000289	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—hematologic cancer	0.000278	0.000287	CcSEcCtD
Nalidixic Acid—Pruritus—Triamcinolone—hematologic cancer	0.000278	0.000286	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—hematologic cancer	0.000275	0.000284	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—hematologic cancer	0.000275	0.000284	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—hematologic cancer	0.000275	0.000284	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—hematologic cancer	0.000273	0.000281	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—hematologic cancer	0.000273	0.000281	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—hematologic cancer	0.000271	0.00028	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—hematologic cancer	0.00027	0.000279	CcSEcCtD
Nalidixic Acid—Rash—Prednisolone—hematologic cancer	0.000269	0.000277	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisolone—hematologic cancer	0.000269	0.000277	CcSEcCtD
Nalidixic Acid—Headache—Prednisolone—hematologic cancer	0.000267	0.000276	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—hematologic cancer	0.000267	0.000275	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—hematologic cancer	0.000266	0.000274	CcSEcCtD
Nalidixic Acid—Dizziness—Triamcinolone—hematologic cancer	0.000259	0.000268	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—hematologic cancer	0.000259	0.000267	CcSEcCtD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—NQO1—hematologic cancer	0.000258	0.0182	CbGpPWpGaD
Nalidixic Acid—Convulsion—Epirubicin—hematologic cancer	0.000257	0.000266	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—hematologic cancer	0.000257	0.000265	CcSEcCtD
Nalidixic Acid—Asthenia—Betamethasone—hematologic cancer	0.000255	0.000263	CcSEcCtD
Nalidixic Acid—Asthenia—Dexamethasone—hematologic cancer	0.000255	0.000263	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—hematologic cancer	0.000254	0.000262	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—hematologic cancer	0.000254	0.000261	CcSEcCtD
Nalidixic Acid—Nausea—Prednisolone—hematologic cancer	0.000253	0.000261	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—hematologic cancer	0.000253	0.000261	CcSEcCtD
Nalidixic Acid—Pruritus—Betamethasone—hematologic cancer	0.000252	0.00026	CcSEcCtD
Nalidixic Acid—Pruritus—Dexamethasone—hematologic cancer	0.000252	0.00026	CcSEcCtD
Nalidixic Acid—Vomiting—Triamcinolone—hematologic cancer	0.000249	0.000257	CcSEcCtD
Nalidixic Acid—Rash—Triamcinolone—hematologic cancer	0.000247	0.000255	CcSEcCtD
Nalidixic Acid—Dermatitis—Triamcinolone—hematologic cancer	0.000247	0.000255	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—hematologic cancer	0.000247	0.000255	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisone—hematologic cancer	0.000246	0.000254	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—hematologic cancer	0.000246	0.000254	CcSEcCtD
Nalidixic Acid—Headache—Triamcinolone—hematologic cancer	0.000246	0.000254	CcSEcCtD
Nalidixic Acid—Abdominal pain—Prednisone—hematologic cancer	0.000245	0.000253	CcSEcCtD
Nalidixic Acid—Diarrhoea—Betamethasone—hematologic cancer	0.000244	0.000251	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dexamethasone—hematologic cancer	0.000244	0.000251	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—hematologic cancer	0.000242	0.00025	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—hematologic cancer	0.000238	0.000246	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—hematologic cancer	0.000237	0.000245	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000236	0.000243	CcSEcCtD
Nalidixic Acid—Dizziness—Dexamethasone—hematologic cancer	0.000235	0.000243	CcSEcCtD
Nalidixic Acid—Dizziness—Betamethasone—hematologic cancer	0.000235	0.000243	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—hematologic cancer	0.000234	0.000241	CcSEcCtD
Nalidixic Acid—Nausea—Triamcinolone—hematologic cancer	0.000233	0.00024	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—hematologic cancer	0.000233	0.00024	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—hematologic cancer	0.00023	0.000238	CcSEcCtD
Nalidixic Acid—Vomiting—Betamethasone—hematologic cancer	0.000226	0.000233	CcSEcCtD
Nalidixic Acid—Vomiting—Dexamethasone—hematologic cancer	0.000226	0.000233	CcSEcCtD
Nalidixic Acid—Rash—Dexamethasone—hematologic cancer	0.000224	0.000232	CcSEcCtD
Nalidixic Acid—Rash—Betamethasone—hematologic cancer	0.000224	0.000232	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000224	0.000231	CcSEcCtD
Nalidixic Acid—Dermatitis—Dexamethasone—hematologic cancer	0.000224	0.000231	CcSEcCtD
Nalidixic Acid—Dermatitis—Betamethasone—hematologic cancer	0.000224	0.000231	CcSEcCtD
Nalidixic Acid—Headache—Dexamethasone—hematologic cancer	0.000223	0.00023	CcSEcCtD
Nalidixic Acid—Headache—Betamethasone—hematologic cancer	0.000223	0.00023	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—hematologic cancer	0.000222	0.000229	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000221	0.000228	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—hematologic cancer	0.00022	0.000227	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—hematologic cancer	0.000219	0.000226	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—hematologic cancer	0.000218	0.000225	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—hematologic cancer	0.000216	0.000222	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—hematologic cancer	0.000212	0.000219	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000212	0.000219	CcSEcCtD
Nalidixic Acid—Nausea—Dexamethasone—hematologic cancer	0.000211	0.000218	CcSEcCtD
Nalidixic Acid—Nausea—Betamethasone—hematologic cancer	0.000211	0.000218	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—hematologic cancer	0.000206	0.000212	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisone—hematologic cancer	0.000205	0.000211	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—hematologic cancer	0.000205	0.000211	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000204	0.000211	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—hematologic cancer	0.000201	0.000208	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—hematologic cancer	0.000199	0.000206	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000198	0.000205	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—hematologic cancer	0.000197	0.000203	CcSEcCtD
Nalidixic Acid—Rash—Prednisone—hematologic cancer	0.000195	0.000202	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—hematologic cancer	0.000195	0.000201	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—hematologic cancer	0.000194	0.0002	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—hematologic cancer	0.000193	0.000199	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—hematologic cancer	0.000192	0.000198	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—hematologic cancer	0.000186	0.000192	CcSEcCtD
Nalidixic Acid—Nausea—Prednisone—hematologic cancer	0.000184	0.00019	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000183	0.000189	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—hematologic cancer	0.000183	0.000189	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—hematologic cancer	0.000178	0.000184	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—hematologic cancer	0.000177	0.000183	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—hematologic cancer	0.000177	0.000183	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GMPS—hematologic cancer	0.000177	0.0125	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PHYH—hematologic cancer	0.000177	0.0125	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—FTCD—hematologic cancer	0.000177	0.0125	CbGpPWpGaD
Nalidixic Acid—Asthenia—Epirubicin—hematologic cancer	0.000174	0.000179	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—hematologic cancer	0.000172	0.000177	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—hematologic cancer	0.000171	0.000177	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—hematologic cancer	0.000166	0.000171	CcSEcCtD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000165	0.0116	CbGpPWpGaD
Nalidixic Acid—Vomiting—Methotrexate—hematologic cancer	0.000165	0.00017	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—hematologic cancer	0.000163	0.000169	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—hematologic cancer	0.000163	0.000168	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—hematologic cancer	0.000162	0.000167	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SMPD3—hematologic cancer	0.000162	0.0114	CbGpPWpGaD
Nalidixic Acid—Asthenia—Doxorubicin—hematologic cancer	0.000161	0.000166	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—hematologic cancer	0.00016	0.000165	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—hematologic cancer	0.000159	0.000164	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—hematologic cancer	0.000154	0.000159	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—hematologic cancer	0.000154	0.000159	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—hematologic cancer	0.000154	0.000158	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—hematologic cancer	0.000153	0.000158	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—hematologic cancer	0.000153	0.000158	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—hematologic cancer	0.000152	0.000157	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—hematologic cancer	0.000148	0.000153	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—hematologic cancer	0.000144	0.000149	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—hematologic cancer	0.000143	0.000147	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—hematologic cancer	0.000141	0.000146	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—hematologic cancer	0.000141	0.000146	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—B3GAT1—hematologic cancer	0.000141	0.00997	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—DCK—hematologic cancer	0.000141	0.00997	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ASNS—hematologic cancer	0.000141	0.00997	CbGpPWpGaD
Nalidixic Acid—Headache—Doxorubicin—hematologic cancer	0.000141	0.000145	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HDC—hematologic cancer	0.000134	0.00945	CbGpPWpGaD
Nalidixic Acid—Nausea—Doxorubicin—hematologic cancer	0.000133	0.000137	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000127	0.00897	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CDA—hematologic cancer	0.000123	0.00865	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PC—hematologic cancer	0.000118	0.00832	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC35B2—hematologic cancer	0.000114	0.00804	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GBA—hematologic cancer	0.000114	0.00804	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000113	0.00799	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—MTAP—hematologic cancer	0.000104	0.00735	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—FHL2—hematologic cancer	9.28e-05	0.00655	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	9.17e-05	0.00647	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AGRN—hematologic cancer	9.11e-05	0.00643	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—IDH2—hematologic cancer	8.63e-05	0.00609	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HMMR—hematologic cancer	8.63e-05	0.00609	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	8.52e-05	0.00601	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ARNTL—hematologic cancer	8.12e-05	0.00573	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CA9—hematologic cancer	7.89e-05	0.00557	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ACP5—hematologic cancer	7.89e-05	0.00557	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NCOR2—hematologic cancer	7.79e-05	0.0055	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	7.49e-05	0.00529	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—IDH1—hematologic cancer	7.42e-05	0.00524	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—TXN—hematologic cancer	7.34e-05	0.00518	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCC3—hematologic cancer	7.34e-05	0.00518	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTO1—hematologic cancer	7.34e-05	0.00518	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SPHK1—hematologic cancer	7.18e-05	0.00507	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	7.07e-05	0.00499	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	6.95e-05	0.0049	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UGT1A1—hematologic cancer	6.9e-05	0.00487	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	6.82e-05	0.00481	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CRABP1—hematologic cancer	6.71e-05	0.00474	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC22A1—hematologic cancer	6.71e-05	0.00474	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALOX5—hematologic cancer	6.54e-05	0.00462	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	6.46e-05	0.00456	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NUP98—hematologic cancer	6.34e-05	0.00447	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ADCY7—hematologic cancer	6.15e-05	0.00434	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NCOA3—hematologic cancer	6.15e-05	0.00434	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NUP214—hematologic cancer	6.11e-05	0.00431	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	6.07e-05	0.00429	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—MTR—hematologic cancer	5.98e-05	0.00422	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCG2—hematologic cancer	5.98e-05	0.00422	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ENO2—hematologic cancer	5.87e-05	0.00414	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	5.76e-05	0.00406	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—hematologic cancer	5.69e-05	0.00402	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SDC1—hematologic cancer	5.56e-05	0.00393	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	5.27e-05	0.00372	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	5.27e-05	0.00372	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	5.27e-05	0.00372	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	4.74e-05	0.00335	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CD44—hematologic cancer	4.73e-05	0.00334	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NQO1—hematologic cancer	4.73e-05	0.00334	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYCS—hematologic cancer	4.48e-05	0.00316	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HSP90AA1—hematologic cancer	4.45e-05	0.00314	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.16e-05	0.00294	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTP1—hematologic cancer	3.94e-05	0.00278	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	3.81e-05	0.00269	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCB1—hematologic cancer	3.73e-05	0.00263	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—hematologic cancer	3.62e-05	0.00256	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NCOR1—hematologic cancer	3.62e-05	0.00256	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.59e-05	0.00254	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.49e-05	0.00246	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.46e-05	0.00244	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.39e-05	0.00239	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—MTHFR—hematologic cancer	3.2e-05	0.00226	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.02e-05	0.00213	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CG—hematologic cancer	2.69e-05	0.0019	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.61e-05	0.00184	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.54e-05	0.00179	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CREBBP—hematologic cancer	2.5e-05	0.00176	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CD—hematologic cancer	2.37e-05	0.00167	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALB—hematologic cancer	2.34e-05	0.00165	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3R1—hematologic cancer	2.23e-05	0.00158	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.12e-05	0.00149	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CB—hematologic cancer	2.06e-05	0.00146	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTEN—hematologic cancer	1.78e-05	0.00126	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—EP300—hematologic cancer	1.7e-05	0.0012	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.42e-05	0.000999	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.32e-05	0.000935	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—hematologic cancer	1.26e-05	0.000887	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AKT1—hematologic cancer	1.03e-05	0.000725	CbGpPWpGaD
